InsidersTradesSigma
Follow the JW중외제약 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, JW중외제약 has recorded 37 insider filings. Market capitalisation: €521.9bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: JW홀딩스. The full history is accessible without an account.
37
Insider Decl.
n/a
Thresholds
n/a
19 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,017 of 29,053 companies
81.1
score / 100
Value89
Quality73
FCF yld12%
Earn yld12%
EV/EBITDA5.1x
ROE20%
Gross mgn46%
Net mgn7.9%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 March 2026
Declarations37 total
25 of 37 declarations
About JW중외제약
JW Pharmaceutical is a South Korean pharmaceutical company focused on the development and commercialization of medications. It is listed on the Korea Exchange, XKRX.